Earnings History Data for ProQR Therapeutics N.V. (PRQR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ProQR Therapeutics N.V.
ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2023 | PM | PRQR | ProQR Therapeutics | 98.00 | -0.08 | -0.06 | 0.00 | ProQR GAAP EPS of -€0.07, revenue of €1.37M [11/7/2023 8:01 AM] |
1.35 | 0.13 (10.66%) |
0.0 | 0.0 (0.00%) |
0.86 - 3.85 | 565,319 | 150,000 | 0 | ||
| 16-05-2023 | PM | PRQR | ProQR Therapeutics | 157.00 | -0.12 | -0.12 | 0.00 | ProQR GAAP EPS of -€0.11, revenue of €0.66M [5/16/2023 7:18 AM] |
1.76 | -0.16 (-8.33%) |
0.0 | 0.0 (0.00%) |
0.59 - 3.85 | 879,713 | 420,000 | 0 | ||
| 09-11-2022 | PM | PRQR | ProQR Therapeutics | 66.00 | -0.34 | -0.23 | 0.00 | ProQR GAAP EPS of -€0.34, revenue of €0.96M [11/9/2022 8:35 AM] |
0.8965 | -0.03 (-2.98%) |
0.90 | -0.02 (-2.60%) |
0.53 - 8.60 | 1,100,784 | 620,000 | 80,294 | ||
| 04-11-2021 | PM | PRQR | ProQR Therapeutics | 402.00 | -0.26 | -0.23 | 0.00 | ProQR reports Q3 results [11/4/2021 7:49 AM] |
8.27 | 0.44 (5.62%) |
8.27 | 0.0 (0.00%) |
3.40 - 9.46 | 568,119 | 280,000 | 27,145 | ||
| 06-05-2021 | PM | PRQR | ProQR Therapeutics N.V. | 420.57 | -0.30 | -0.26 | -0.35 | ProQR reports Q1 results [5/6/2021 7:31 AM] |
5.88 | -0.31 (-5.01%) |
5.88 | 0.0 (0.00%) |
3.40 - 9.46 | 1,046,163 | 700,000 | 7,121 | ||
| 25-02-2021 | PM | PRQR | ProQR Therapeutics N.V. | 248.73 | -0.31 | -0.30 | -0.43 | ProQR EPS beats by $0.05 [2/25/2021 7:24 AM] |
4.76 | 0.40 (9.31%) |
4.76 | 0.0 (0.11%) |
3.40 - 8.69 | 533,725 | 585,132 | 801 | ||